Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,258Revenue $M478Net Margin (%)10.6Z-Score11.9
Enterprise Value $M2,028EPS $0.9Operating Margin %14.6F-Score5
P/E(ttm))47.6Cash Flow Per Share $1.8Pre-tax Margin (%)14.3Higher ROA y-yN
Price/Book3.710-y EBITDA Growth Rate %15.5Quick Ratio4.2Cash flow > EarningsY
Price/Sales5.05-y EBITDA Growth Rate %1.5Current Ratio5.0Lower Leverage y-yY
Price/Cash Flow21.5y-y EBITDA Growth Rate %-26.5ROA % (ttm)6.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)7.6Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M53.7ROI % (ttm)7.8Gross Margin Increase y-yN

Gurus Latest Trades with THOR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
THORJoel Greenblatt 2014-12-31 Sold Out -0.26%$25.49 - $32.91
($29.17)
$ 42.3131%Sold Out0
THORJoel Greenblatt 2014-09-30 Add0.15%$22.74 - $34.99
($28.15)
$ 42.3133%Add 140.96%970,893
THORJoel Greenblatt 2014-06-30 Buy 0.18%$30.89 - $36.14
($33.31)
$ 42.3121%New holding402,924
THORJoel Greenblatt 2014-03-31 Sold Out -0.01%$33.8 - $38.66
($35.87)
$ 42.3115%Sold Out0
THORJoel Greenblatt 2013-12-31 Buy 0.01%$35.85 - $43.3
($39.3)
$ 42.317%New holding8,481
THORJoel Greenblatt 2013-09-30 Sold Out -0.12%$30.7 - $37.64
($34.95)
$ 42.3117%Sold Out0
THORJoel Greenblatt 2013-03-31 Add0.07%$35.22 - $38.12
($36.37)
$ 42.3114%Add 55.06%109,834
THORJoel Greenblatt 2012-09-30 Reduce-0.05%$31.17 - $36.03
($33.76)
$ 42.3120%Reduce -20.46%72,252
THORJoel Greenblatt 2012-06-30 Add0.12%$29.75 - $35.87
($32.48)
$ 42.3123%Add 122.67%90,834
THORJoel Greenblatt 2012-03-31 Add0.05%$29 - $35.72
($30.72)
$ 42.3127%Add 72.67%40,793
THORJoel Greenblatt 2011-12-31 Add0.03%$28.16 - $37.37
($32.27)
$ 42.3124%Add 52.64%23,625
THORGeorge Soros 2011-12-31 Sold Out -0.0002%$28.16 - $37.37
($32.27)
$ 42.3124%Sold Out0
THORJoel Greenblatt 2011-09-30 Reduce-0.03%$30.16 - $36.64
($33.1)
$ 42.3122%Reduce -32.52%15,478
THORGeorge Soros 2011-09-30 Buy $30.16 - $36.64
($33.1)
$ 42.3122%New holding400
THORJoel Greenblatt 2011-06-30 Reduce-0.09%$26.42 - $35.7
($31.36)
$ 42.3126%Reduce -33.02%22,936
THORJoel Greenblatt 2011-03-31 Add0.1%$23.06 - $31.2
($27.05)
$ 42.3136%Add 55.11%34,241
THORJoel Greenblatt 2010-12-31 Buy 0.2%$24.74 - $37.26
($30.37)
$ 42.3128%New holding22,076
THORGeorge Soros 2010-12-31 Sold Out -0.06%$24.74 - $37.26
($30.37)
$ 42.3128%Sold Out0
THORGeorge Soros 2010-09-30 Buy 0.06%$32.2 - $44.97
($38.31)
$ 42.319%New holding100,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

THOR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


THOR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DIMICK NEIL FDirector 2015-04-10Sell4,786$43-0.53view
COLE J DANIELDirector 2014-12-04Sell5,000$31.8334.37view
DIMICK NEIL FDirector 2014-05-27Sell4,158$32.1533.03view
DIMICK NEIL FDirector 2014-05-19Sell625$31.3536.43view
LAVIOLETTE PAUL ADirector 2014-05-15Sell6,023$31.2336.95view
Burbach Gerhard FCEO 2014-03-10Sell22,104$36.5317.08view
Burbach Gerhard FCEO 2014-02-27Sell5,000$3715.59view
Burbach Gerhard FCEO 2014-02-12Sell5,000$36.0118.77view
Burbach Gerhard FCEO 2014-02-11Sell20,000$34.7123.22view
Burbach Gerhard FCEO 2014-01-15Sell9,400$38.112.26view

Press Releases about THOR :

    Quarterly/Annual Reports about THOR:

    News about THOR:

    Articles On GuruFocus.com
    5-year lows: Thoratec Corp, Brady Corp, General Cable Corp, and UTi Worldwide Inc. Aug 25 2014 
    5-year lows: Mack-Cali Realty Corp, Thoratec Corp, Brady Corp, and EXCO Resources Inc. Aug 10 2014 
    5 Strong Healthcare Stocks For 2012 Mar 24 2012 
    Consider These 5 Healthcare Stocks Now Mar 21 2012 
    Weekly Guru Bargains Highlights: CSTR, VRX, SAY, THOR, BVN Feb 12 2011 
    Weekly Guru Bargains Highlights: CSTR, VRX, SAY, THOR, BVN Feb 12 2011 
    Weekly Guru Bargains Highlights: SVU, MSI, THOR, JNY, AMLN Jan 23 2011 
    Weekly Guru Bargains Highlights: DF, CLWR, THOR, VRX, ASIA Dec 26 2010 
    Weekly Guru Bargains Highlights: TFSL, THOR, CISG, VRX, DLR Dec 18 2010 
    Weekly Guru Bargains Highlights: THOR, SKX, AMLN, SAY, JOE Dec 12 2010 


    More From Other Websites
    Thoratec Schedules First Quarter Conference Call, Webcast Apr 20 2015
    Thoratec Schedules First Quarter Conference Call, Webcast Apr 20 2015
    Thoratec's HeartMate II Scores High in ENDURANCE Trial - Analyst Blog Apr 17 2015
    ROADMAP Study Demonstrates HeartMate II® Benefits In Ambulatory Advanced Heart Failure Patients Apr 17 2015
    ROADMAP Study Demonstrates HeartMate II® Benefits In Ambulatory Advanced Heart Failure Patients Apr 17 2015
    ROADMAP Study Demonstrating Benefits of HeartMate II(R) Left Ventricular Assist Device Presented at... Apr 17 2015
    Thoratec Hits 52-Week High on Favorable Developments - Analyst Blog Apr 16 2015
    Thoratec Comments On HeartMate II® Data In ENDURANCE Destination Therapy Trial Apr 16 2015
    Thoratec Comments On HeartMate II® Data In ENDURANCE Destination Therapy Trial Apr 16 2015
    HeartWare Gets VAD Distribution Approval from Health Canada - Analyst Blog Apr 15 2015
    Medtronic PLC (MDT), AbbVie Inc. (ABBV), Humana Inc (HUM): Rock Springs Capital Rides Healthcare... Apr 14 2015
    THORATEC CORP Files SEC form 8-K, Change in Directors or Principal Officers Apr 08 2015
    Thoratec Wins FDA Consent to Expand HeartMate III US Trial - Analyst Blog Apr 06 2015
    Thoratec To Webcast Investor Meeting At ISHLT Conference Apr 06 2015
    Thoratec To Webcast Investor Meeting At ISHLT Conference Apr 06 2015
    Thoratec Receives Approval From FDA For Full Expansion Of HeartMate III™ U.S. IDE Clinical Trial Apr 02 2015
    Thoratec Receives Approval From FDA For Full Expansion Of HeartMate III™ U.S. IDE Clinical Trial Apr 02 2015
    How to Play the Healthcare Rally Apr 01 2015
    Thoratec® Reports Fourth Quarter 2014 Results Mar 06 2015
    Heartware International Posts Q4 Loss; MVAD Holds Promise - Analyst Blog Mar 06 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK